Clorox (CLX) Misses Q3 EPS by 12c, Misses on Revenue; Offers FY25 EPS Guidance

Clorox (NYSE: CLX) reported Q3 EPS of $1.45, $0.12 worse than the analyst estimate of $1.57. Revenue for the quarter came in at $1.67 billion versus the consensus estimate of $1.73 billion.

GUIDANCE:

Clorox sees FY2025 EPS of $6.95-$7.35, versus the consensus of $7.12.

For earnings history and earnings-related data on Clorox (CLX) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low
• Golden Spike Resources plans name change, share consolidation and C$500K raise